Revolution Medicines ratios data for the quarter ended Jun 2026. These financial ratios cover 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||
| EBT Margin | -4,808.36% | -556.83% | -760.72% | -671.59% | -2,193.86% | -369.41% | -970.89% | -2,570.55% | -21,831.00% | |||||||||||||||||||||
| EBIT Margin | -4,828.61% | -559.33% | -764.70% | -681.10% | -2,280.48% | -402.52% | -1,071.53% | -2,845.11% | -24,256.47% | |||||||||||||||||||||
| EBITDA Margin | -4,828.61% | -559.33% | -764.70% | -681.10% | -2,280.48% | -402.52% | -1,071.53% | -2,845.11% | -24,256.47% | |||||||||||||||||||||
| Operating Margin | -4,828.61% | -559.33% | -764.70% | -681.10% | -2,280.48% | -402.52% | -1,071.53% | -2,845.11% | -24,256.47% | |||||||||||||||||||||
| Net Margin | -4,808.36% | -556.83% | -760.72% | -671.59% | -2,185.01% | -368.60% | -970.89% | -2,570.55% | -21,770.49% | |||||||||||||||||||||
| FCF Margin | -3,364.40% | -427.57% | -752.82% | -638.90% | -1,646.66% | -421.81% | -914.59% | -1,784.52% | -16,145.15% | |||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 754.51M | 736.48M | 710.38M | 657.79M | 729.36M | 818.92M | 942.59M | 1,073.48M | 1,028.97M | 1,522.97M | 1,985.03M | 1,858.40M | 1,785.72M | 2,160.65M | 2,461.83M | 2,397.46M | 2,340.74M | 2,303.21M | 2,304.12M | 3,288.50M | ||||||||||
| Asset Utilization RatioAsset Util. | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -50.15 | 77.01 | -305.32 | -27.59 | -30.30 | -36.50 | -21.24 | |||||||||||||||||||||||
| Times Interest Earned | -50.15 | 77.01 | -305.32 | -27.59 | -30.30 | -36.50 | -21.24 | |||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -4,828.61% | -559.33% | -764.70% | -681.10% | -2,280.48% | -402.52% | -1,071.53% | -2,845.11% | -1,409.77% | -24,256.47% | -12,108.78% | -80,961.32% | -88,031.94% | |||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -24.08% | -27.81% | -31.94% | -38.05% | -38.03% | -34.12% | -31.02% | -32.37% | -39.10% | -35.33% | -29.23% | -34.27% | -39.00% | -34.53% | -34.27% | -40.56% | -49.50% | -58.74% | -68.84% | -55.45% | ||||||||||
| Return on Assets [ROA]ROA | -22.35% | -25.40% | -29.22% | -34.13% | -33.57% | -30.37% | -27.49% | -27.60% | -32.20% | -28.70% | -24.44% | -27.98% | -31.80% | -27.77% | -28.33% | -33.87% | -41.05% | -49.12% | -59.53% | -53.77% |